Mirum Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Mirum Pharmaceuticals, Inc. (MIRM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents222.50286.33151.7231.34142.09116.66
Short-Term Investments57.810.00123.72125.2089.730.00
Cash & Short-Term Investments280.32286.33151.72156.54231.82116.66
Accounts Receivable78.2967.9723.993.270.000.00
Inventory22.4022.315.571.510.000.00
Other Current Assets11.7810.949.255.274.531.49
Total Current Assets392.79387.54190.23166.59236.35119.36
Non-Current Assets
Property, Plant & Equipment (Net)9.811.992.352.553.243.73
Long-Term Investments12.530.000.004.980.000.00
Intangible Assets249.82252.9358.9518.740.000.00
Other Non-Current Assets5.814.171.38101.791.270.32
Total Non-Current Assets277.97259.0862.68128.064.5127.35
Total Assets670.75646.62352.91294.65240.86146.71
Current Liabilities
Accounts Payable14.627.4262.719.173.1512.68
Short-Term Debt1.710.000.000.000.000.00
Accrued Liabilities72.8650.8934.7320.1313.410.00
Other Current Liabilities37.3623.6514.662.001.260.00
Total Current Liabilities126.5587.0664.7342.6018.4613.08
Non-Current Liabilities
Long-Term Debt308.08306.421.261.902.633.25
Other Non-Current Liabilities2.513.854.530.0247.680.04
Total Non-Current Liabilities318.56310.89146.14131.8450.313.29
Total Liabilities445.11397.95210.87174.4468.7716.36
Stockholders' Equity
Common Stock0.010.010.000.000.000.00
Retained Earnings-644.18-556.24-393.04-257.16-173.17-69.90
Accumulated Other Comprehensive Income-0.371.64-0.22-0.040.080.13
Additional Paid-in Capital870.19803.26535.07377.40345.18200.12
Shares Outstanding48.3446.7236.9630.580.000.00
Total Stockholders' Equity225.64248.67142.04120.21172.10130.35
Total Liabilities & Equity670.75646.62352.91294.65240.86146.71